We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
More people living with obesity will have access to the newest and most effective obesity drugs to help cut NHS waiting lists, following the announcement of a £40 million two-year pilot today [Wednesday 7 June].
Information about the risks of taking valproate medicines during pregnancy.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
The MHRA has re-issued this notification as Class 3 recall based on further assessment. Please note the new actions for healthcare professionals listed within the notification. Doncaster Pharma Limited have identified an error relating to the Braille printed on the...
Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets due to an error on the foil blister packaging.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
This series brings together all documents relating to drugs licensing.
Guidance for prisons on the reintroduction of disinfecting tablets for use by prisoners.
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
This series brings together all documents relating to the UK government’s 10-year drugs strategy.
How the MHRA makes decisions on what is a medicinal product (borderline products).
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
This essential guide for drug and treatment professionals provides the most up to date scientific evidence on the health harms arising from drug misuse.
The most commonly encountered drugs currently controlled under the misuse of drugs legislation.
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.
Two pharmacists who sold ‘industrial’ quantities of Class C controlled drugs were yesterday sentenced to two years’ imprisonment each, suspended for 24 months, at Southwark Crown Court following an investigation by the Criminal Enforcement Unit of the Medicines and Healthcare...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).